Filing Flows › Comparisons › SKVI vs PULM
Skinvisible vs Pulmatrix: SKVI and PULM compared
Skinvisible is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $3K for Pulmatrix (Q4 2024). Skinvisible is growing faster (0% against -100% a year earlier).
Where the money goes: SKVI and PULM
Skinvisible (SKVI) · Q2 2026
Skinvisible, Q2 2026: revenue $5K (0% year over year), net loss $256K, operating cash flow $2K. The chart follows the revenue to costs, profit and cash.
Pulmatrix (PULM) · Q4 2024
Pulmatrix, Q4 2024: revenue $3K (-100% year over year), net loss $2.0M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Skinvisible (SKVI) | Pulmatrix (PULM) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 2024 |
| Revenue | $5K | $3K |
| Revenue growth, Y/Y | 0% | -100% |
| Operating margin | n/m | n/m |
| Net earnings | −$256K | −$2.0M |
| Operating cash flow | $2K | −$1.3M |
Questions
Which is bigger, Skinvisible or Pulmatrix?
Skinvisible is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $3K for Pulmatrix (Q4 2024).
Is Skinvisible or Pulmatrix growing faster?
Skinvisible is growing faster (0% against -100% a year earlier).
More: Skinvisible earnings · how Skinvisible makes money · Pulmatrix earnings · how Pulmatrix makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-K filed Mar 21, 2025). Fiscal quarters can end on different dates. Not investment advice.